| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 03/11/2010 | CA2735779A1 Bicyclic kinase inhibitors |
| 03/11/2010 | CA2735521A1 Indolizine inhibitors of leukotriene production |
| 03/10/2010 | EP2161273A1 Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment |
| 03/10/2010 | EP2161272A1 Phenanthrolines |
| 03/10/2010 | EP2161271A1 Alpha-carboline inhibitors of NMP-ALK, RET, and Bcr-Abl |
| 03/10/2010 | EP2161270A1 Gemifloxacin hydrates |
| 03/10/2010 | EP2161269A1 Process for the preparation of amorphous gemifloxacin |
| 03/10/2010 | EP2161258A2 4-oxoquinoline compound and use thereof as hiv integrase inhibitor |
| 03/10/2010 | EP2027122B1 Novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives and their medical use |
| 03/10/2010 | EP1863818B1 Acetylenyl-pyrazolo-pvrimidine derivatives as mglur2 antagonists |
| 03/10/2010 | EP1828182B1 Therapeutic pyrazolo[3,4-b]pyridines and indazoles |
| 03/10/2010 | EP1781296B1 Quinazoline derivatives and their use in the treatment of thrombocythemia |
| 03/10/2010 | EP1377293B1 Aryl and biaryl piperidines used as mch antagonists |
| 03/10/2010 | CN101668760A Aminopyrimidines useful as inhibitors of protein kinases |
| 03/10/2010 | CN101668759A [6,5]-bicyclic gpr119 g protein-coupled receptor agonists |
| 03/10/2010 | CN101668758A Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 03/10/2010 | CN101668757A Pyrrolo [2, 3-b] pyridine derivatives as kinase modulators |
| 03/10/2010 | CN101665492A 1, 6, 7, 12-tetraphenyl perylene bisimide derivant and preparation method thereof |
| 03/09/2010 | US7674906 4-[4-(4-Amino-phenyl)-3-oxo-3,5-dihydro-pyrazolo[4,3-c]quinolin-2-yl]-benzoic acid methyl ester; rheumatoid arthritis, multiple sclerosis, diabetes, asthma, transplantation, systemic lupus erythematosis and psoriasis; CD80 antagonists capable of inhibiting the interactions between CD80 and CD28 |
| 03/09/2010 | US7674902 Luminescent metal complexes for monitoring renal function |
| 03/09/2010 | US7674823 DNA-PK inhibitors |
| 03/09/2010 | US7674803 Thiazolypiperidine derivatives as MTP inhibitors |
| 03/09/2010 | US7674801 e.g. Methyl 2-(6-{[(ethylamino)carbonyl]amino}pyridin-3-yl)-1,3-thiazole-5-carboxylate; bacterial DNA gyrase or bacterial topoisomerase IV inhibitor; antibacterial agent; antibiotic resistance; skin structure infections, pneumoniae, bronchitis, acute sinusitis, otitis media, sepsis, osteomyelitis |
| 03/09/2010 | US7674795 Fluorene derivatives, composition containing said derivatives and the use thereof |
| 03/09/2010 | CA2379282C Amido spiropiperidines promote the release of growth hormone |
| 03/09/2010 | CA2228847C Ibogamine congeners |
| 03/04/2010 | WO2010025202A1 PYRIDO[3,2-d]PYRIDAZINE-2(1H)-ONE COMPOUNDS AS P38 MODULATORS AND METHODS OF USE THEREOF |
| 03/04/2010 | WO2010025201A1 Pyridazino- pyridinone compounds for the treatment of protein kinase mediated diseases. |
| 03/04/2010 | WO2010025197A1 Process for preparing certain cinnamide compounds |
| 03/04/2010 | WO2010024980A1 4'-amino cyclic compounds having 5-ht6 receptor affinity |
| 03/04/2010 | WO2010024717A1 Ligand with a broad spectrum of pharmacological activity, a pharmaceutical composition, a medicinal agent and a method of treatment |
| 03/04/2010 | WO2010024430A1 2,4-diaminopyrimidine compound |
| 03/04/2010 | WO2010024356A1 Novel hydroxamic acid derivative having naphthyridine-n-oxide |
| 03/04/2010 | WO2010023561A1 Process for preparing varenicline, varenicline intermediates, and pharmaceutically acceptable salts thereof |
| 03/04/2010 | WO2010022850A1 Fused pyrrolidino-cyclopropane derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors |
| 03/04/2010 | WO2010005520A3 Deuterated ibudilast |
| 03/04/2010 | WO2010004198A3 Antineoplastic derivatives of 4-oxo-l, 4-dihydro-quinolinξ, preparation thereof, and therapeutic use thereof |
| 03/04/2010 | US20100056791 Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor containing the same |
| 03/04/2010 | US20100056790 Fluoro-containing derivatives of hydrogenated pyrido[4,3-b]indoles with neuroprotective and cognition enhancing properties, process for preparing, and use |
| 03/04/2010 | US20100056571 Novel pyrazole compounds as transforming growth factor (tgf) inhibitors |
| 03/04/2010 | US20100056563 Novel 1.8-naphthyridine compounds |
| 03/04/2010 | US20100056558 1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as lipid kinase inhibitors |
| 03/04/2010 | US20100056556 Isoquinolinopyrrolopyridinones active as kinase inhibitors |
| 03/04/2010 | US20100056549 Highly soluble pyrimido-dione-quinoline compounds and their use in the treatment of cancer |
| 03/04/2010 | US20100056539 Trazodone and trazodone hydrochloride in purified form |
| 03/04/2010 | US20100056522 Intraocular pressure-lowering agent comprising compound having histone deacetylase inhibitor effect as active ingredient |
| 03/04/2010 | US20100056521 (aza)indole derivative and use thereof for medical purposes |
| 03/04/2010 | US20100056516 1-hydroxy naphthyridine compounds as anti-hiv agents |
| 03/04/2010 | US20100056511 2- [ (2-substituted) -ind0lizin-3-yl] -2-oxo-acetamide derivatives as antifungal agents |
| 03/04/2010 | US20100056509 Heteroaryl sulfonamides and ccr2 |
| 03/04/2010 | US20100056499 3-amino-1-arylpropyl azaindoles and uses thereof |
| 03/04/2010 | US20100056498 Substituted monocyclic cgrp receptor antagonists |
| 03/04/2010 | US20100056495 Dimeric iap inhibitors |
| 03/04/2010 | US20100056491 4'-amino cyclic compounds having 5-ht6 receptor affinity |
| 03/04/2010 | US20100055687 Mutations in the BCR-ABL tyrosine kinase associated with resistance to ST1-571 |
| 03/04/2010 | US20100055071 Anti-Viral Compounds |
| 03/04/2010 | CA2735730A1 2,4-diaminopyrimidine compound |
| 03/04/2010 | CA2735286A1 Fused pyrrolidino-cyclopropane derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors |
| 03/04/2010 | CA2733606A1 Process for preparing certain cinnamide compounds |
| 03/03/2010 | EP2159225A1 Gemifloxacin process and polymorphs |
| 03/03/2010 | EP2158201A2 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics |
| 03/03/2010 | EP2158194A2 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics |
| 03/03/2010 | EP1910360B1 Hiv reverse transcriptase inhibitors |
| 03/03/2010 | EP1888580B1 Pyrido[2,3-d]pyrimidines useful as hcv inhibitors, and methods for the preparation thereof |
| 03/03/2010 | EP1541575B1 Novel process for producing imidazo(1,2-b)pyridazine derivative |
| 03/03/2010 | CN101663304A Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 03/03/2010 | CN101663302A Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
| 03/03/2010 | CN101663301A Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists |
| 03/03/2010 | CN101663300A Compound wherein substituted bipyridyl group is connected with pyridoindole ring structure through phenylene group, and organic electroluminescent device |
| 03/03/2010 | CN101659668A Process to prepare camptothecin derivatives and novel intermediate and compounds thereof |
| 03/03/2010 | CN101659664A Perylene double imide derivatives and preparation method and applications thereof |
| 03/03/2010 | CN101659663A Indolizine derivative as well as preparation method and application thereof |
| 03/02/2010 | US7671214 Modification of the indolium ring to permit a reactive group or conjugated substance at the 3 ring position unexpectedly mitigates the problems of quenching, difficulty in preparing, strong tendency to self-associate (stack); fluorescent dyes; biomarking; uniformity; intensity; photostability |
| 03/02/2010 | US7671202 Perylene n-type semiconductors and related devices |
| 03/02/2010 | US7671073 4-{(1S,2S)-2-Amino-3-[(3S)-3-fluoropyrrolidin-1-yl]-1-methyl-3-oxopropyl}-1-[1,2,4]triazolo[1,5-a]pyridin-6-ylcyclohexanol, bis(trifluoroacetic acid); non-insulin dependent (Type 2) diabetes, hyperglycemia; dipeptidyl peptidase-IV inhibitors |
| 03/02/2010 | US7671069 chemokine receptor modulators; tumor cell proliferation, metastasis, inflammatory diseases, HIV, stem cell differentiation and mobilization disorders, and ocular disorders; N-[2-(cyclohexylmethylamino)-ethyl]-2-(8-Methyl-4-oxo-4H-chromeno[4,3-C]pyrazol-1-yl)-acetamide |
| 03/02/2010 | US7671068 N-(alkoxyalkyl) carbamoyl-substituted 6-phenyl-benzonaphthyridine derivatives and their use as PDE ¾ inhibitors |
| 03/02/2010 | US7671065 Pyridine derivatives as potassium ion channel openers |
| 03/02/2010 | US7671059 (S)-2-Amino-6-benzyl-7-[4-fluoro-2-(2-fluoro-pyridin-3-yl)-phenyl]-4-methyl-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-one;cellular proliferative, viral, autoimmune, cardiovascular, and central nervous system diseases |
| 03/02/2010 | CA2394615C Substituted 1,3,4-oxadiazoles and a method of reducing tnf-.alpha. levels |
| 02/25/2010 | WO2010022081A1 Triazolopyridine compounds as pim kinase inhibitors |
| 02/25/2010 | WO2010022076A1 Triazolopyridine compounds as pim kinase inhibitors |
| 02/25/2010 | WO2010021717A2 Hcv protease inhibitors |
| 02/25/2010 | WO2010021381A1 Fused heterocyclic derivative and use thereof |
| 02/25/2010 | WO2010021247A1 Pharmaceutical preparation, food or beverage having inhibitory activity on serotonin transporter |
| 02/25/2010 | WO2010021149A1 Spiro compound capable of inhibiting acid secretion |
| 02/25/2010 | WO2010020628A1 Novel production method for l-piperidine-4-yl-1,3-dihydro-imidazo [4,5-b] pyridine-2-one and mono- and dihydrochlorides thereof |
| 02/25/2010 | WO2010020556A1 New bradykinin b1 antagonists |
| 02/25/2010 | WO2010020383A1 Method for producing 3,7-diaza-bicyclo[3.3.1] nonane compounds |
| 02/25/2010 | WO2010020363A1 Substituted 5-aminopyrazoles and use thereof |
| 02/25/2010 | WO2010020308A1 7-azaindole derivatives |
| 02/25/2010 | WO2010020000A1 Novel compounds and their uses in diagnosis |
| 02/25/2010 | WO2009158571A8 Heteroaryl compounds and uses thereof |
| 02/25/2010 | WO2009155001A3 Wnt protein signalling inhibitors |
| 02/25/2010 | WO2009140101A3 Imidazopyridine compounds useful as mmp-13 inhibitors |
| 02/25/2010 | WO2009115651A3 N-phenyl-imidazo[1,2-a]pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof |
| 02/25/2010 | WO2009106752A3 Derivatives of 2-heteroaroyl-imidazol[1,2-a]pyridine, preparation thereof and therapeutic application thereof |
| 02/25/2010 | WO2009106751A3 Derivatives of n-heterocyclic-6-heterocyclic-imidazo[l,2- a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 02/25/2010 | WO2009106750A3 Derivatives of 6-heterocyclic-imidazo[l,2-a]pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 02/25/2010 | WO2008139452A3 Selective bromination of perylene diimides and derivatives thereof under mild conditions |